In-depth immunophenotyping of patients with glioblastoma multiforme: Impact of steroid treatment

In-depth immunophenotyping of patients with glioblastoma multiforme: Impact of steroid treatment

Despite aggressive treatment regimens based on surgery and radiochemotherapy, the prognosis of patients with grade IV glioblastoma multiforme (GBM) remains extremely poor, calling for alternative options such as immunotherapy. Immunological mechanisms including the Natural Killer Group 2 member D (N...

Full description

Bibliographic Details
Main Authors: Guranda Chitadze, Charlotte Flüh, Elgar Susanne Quabius, Sandra Freitag-Wolf, Christian Peters, Marcus Lettau, Jaydeep Bhat, Daniela Wesch, Hans-Heinrich Oberg, Stefanie Luecke, Ottmar Janssen, Michael Synowitz, Janka Held-Feindt, Dieter Kabelitz
Format: Article
Language:English
Published: Taylor & Francis Group 2017-11-01
Series:OncoImmunology
Subjects:
dexamethasone
gamma/delta t cells
glioblastoma multiforme
nkg2d
Online Access:http://dx.doi.org/10.1080/2162402X.2017.1358839

Similar Items

Similar Items